Telix Pharmaceuticals LimitedTelix Pharmaceuticals LimitedTelix Pharmaceuticals Limited

Telix Pharmaceuticals Limited

No trades
See on Supercharts

TLX fundamentals

Telix Pharmaceuticals Limited financial statements, including revenue, expenses, profit, and loss

The total revenue of TLX for the last semiannual is 239.54 M USD, and it's 30.32% higher compared to the previous semiannual. The net income of H1 24 is 19.52 M USD.

Q1 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income